Clinical Trials Browser

Has results × Esophageal Neoplasms × Ramucirumab × Clear all

NCT03008278 2026-02-03

Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

Phase 1/2 Completed

51 enrolled 20 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT01246960 2014-10-08

A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

Phase 2 Completed

168 enrolled 16 charts

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms